The deal is expected to close in the second half of 2023.
The post Baxter International to divest BioPharma Solutions business to Advent and Warburg Pincus for $4.2bn appeared first on PE Hub.
Powered by WPeMatico
Securities offered through Burch & Company, Inc. member FINRA/SiPC 4151 N Mulberry Drive, Suite 435 Kansas City, MO 64116
Apex Partners and Burch & Company are not affiliated. Any advisory services discussed on this site that are required to be performed by a registered broker-dealer shall be performed by Burch & Company, Inc., through its registered agents, Barry Harbour or Jim McCoy. Apex Partners is not registered as a broker or dealer and therefore does not perform services that involve securities.
Comments are closed.